Rating History for Enliven Therapeutics (ELVN) by Morgan Stanley
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 10/2/2026 | Sean Laaman | New Coverage | Overweight (N/A) |
70.00 (N/A) |
45.84 (37.32) |
-18.59% | Details |
